ARCHIVES

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005